Pzena Investment Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,662
| Closed | -$298K | – | 156 |
|
|
2025
Q1 | $298K | Sell |
2,662
-561
| -17% | -$62.9K | ﹤0.01% | 139 |
|
|
2024
Q4 | $298K | Buy |
3,223
+599
| +23% | +$55.3K | ﹤0.01% | 141 |
|
|
2024
Q3 | $220K | Sell |
2,624
-1,965
| -43% | -$165K | ﹤0.01% | 156 |
|
|
2024
Q2 | $315K | Sell |
4,589
-1,641
| -26% | -$113K | ﹤0.01% | 154 |
|
|
2024
Q1 | $456K | Buy |
6,230
+359
| +6% | +$26.3K | ﹤0.01% | 148 |
|
|
2023
Q4 | $476K | Sell |
5,871
-130
| -2% | -$10.5K | ﹤0.01% | 147 |
|
|
2023
Q3 | $450K | Buy |
6,001
+56
| +0.9% | +$4.2K | ﹤0.01% | 146 |
|
|
2023
Q2 | $458K | Buy |
5,945
+2,351
| +65% | +$181K | ﹤0.01% | 145 |
|
|
2023
Q1 | $298K | Buy |
+3,594
| New | +$298K | ﹤0.01% | 156 |
|
|
2022
Q1 | – | Sell |
-3,404
| Closed | -$247K | – | 182 |
|
|
2021
Q4 | $247K | Sell |
3,404
-4,720
| -58% | -$342K | ﹤0.01% | 168 |
|
|
2021
Q3 | $567K | Buy |
8,124
+3,700
| +84% | +$258K | ﹤0.01% | 146 |
|
|
2021
Q2 | $305K | Sell |
4,424
-5,881
| -57% | -$405K | ﹤0.01% | 160 |
|
|
2021
Q1 | $666K | Buy |
10,305
+232
| +2% | +$15K | ﹤0.01% | 149 |
|
|
2020
Q4 | $587K | Buy |
10,073
+1,968
| +24% | +$115K | ﹤0.01% | 154 |
|
|
2020
Q3 | $512K | Buy |
+8,105
| New | +$512K | ﹤0.01% | 157 |
|
|
2020
Q1 | – | Sell |
-7,581
| Closed | -$493K | – | 175 |
|
|
2019
Q4 | $493K | Hold |
7,581
| – | – | ﹤0.01% | 165 |
|
|
2019
Q3 | $480K | Buy |
+7,581
| New | +$480K | ﹤0.01% | 164 |
|
|
2017
Q4 | – | Sell |
-2,869
| Closed | -$232K | – | 158 |
|
|
2017
Q3 | $232K | Buy |
+2,869
| New | +$232K | ﹤0.01% | 147 |
|